M&A / Deals Eli Lilly to Acquire Kelonia Therapeutics Big Molecule WatchOn April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc.Read full story pharminent May 4, 2026 (Last updated: May 4, 2026) Big Molecule Watch On April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Gene therapy’s evidence problem–lessons from recent FDA decisionsNext: 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
